Brookfield Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-644,249
| Closed | -$23M | – | 290 |
|
|
2023
Q2 | $23M | Buy |
644,249
+39,429
| +7% | +$1.41M | 0.09% | 82 |
|
|
2023
Q1 | $21.5M | Buy |
604,820
+570,527
| +1,664% | +$20.3M | 0.08% | 95 |
|
|
2022
Q4 | $1.21M | Sell |
34,293
-43
| -0.1% | -$1.51K | ﹤0.01% | 465 |
|
|
2022
Q3 | $1.01M | Sell |
34,336
-346,516
| -91% | -$10.2M | ﹤0.01% | 524 |
|
|
2022
Q2 | $20.7M | Buy |
380,852
+135,647
| +55% | +$7.38M | 0.09% | 89 |
|
|
2022
Q1 | $13.4M | Buy |
245,205
+166,192
| +210% | +$9.05M | 0.05% | 121 |
|
|
2021
Q4 | $4.36M | Buy |
+79,013
| New | +$4.36M | 0.02% | 230 |
|